Indication
Bacterial keratitis
5 clinical trials
15 products
Clinical trial
Evaluation of Antibiogram Results and Clinical Response to Prescribed Antimicrobials in Microbial Keratitis PatientsStatus: Completed, Estimated PCD: 2023-01-01
Product
Moxifloxacin OphthalmicProduct
Ceftazidime + VancomycinProduct
Gentamicin + VancomycinProduct
NatamycinProduct
VoriconazoleProduct
Natamycin + VoriconazoleClinical trial
Rose Bengal Electromagnetic Activation With Green Light for Infection Reduction IIStatus: Not yet recruiting, Estimated PCD: 2024-12-31
Product
DifluprednateProduct
Rose BengalProduct
MoxifloxacinClinical trial
Novel Antisense Oligonucleotide Eye Drops for Treating Antibiotic-Resistant Bacterial KeratitisStatus: Recruiting, Estimated PCD: 2024-10-01
Product
ASOClinical trial
Besifloxacin Ophthalmic Suspension in Patients With Bacterial Keratitis: A Prospective, Randomized Clinical StudyStatus: Completed, Estimated PCD: 2019-06-01
Product
BesifloxacinProduct
Tobramycin + CefazolinClinical trial
Safety and Effectiveness of the PXL Platinum 330 System for Corneal Collagen Cross-Linking With Corneal Thinning ConditionsStatus: Recruiting, Estimated PCD: 2029-09-01
Product
PXL 330